Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label, non-interventional study to evaluate efficacy and safety in rheumatoid
arthritis participants receiving tocilizumab as per the product label.